1,791 followers
RT @FrontNeurol: New Research: Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment: Introduction Plasma…
RT @FrontNeurol: New Research: Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment: Introduction Plasma…
RT @FrontNeurol: New Research: Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment: Introduction Plasma…
New Research: Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment: Introduction Plasma Aβ42/40 ratio can help predict amyloid PET status, but its clinical utility in Alzheimer’s disease (AD) assessment is… https://t.co/9